- Home
- MCRB vs YMT Comparison
MCRB vs YMT Comparison
Compare MCRB & YMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- YMT
- Stock Information
- Founded
- MCRB 2010
- YMT 2011
- Country
- MCRB United States
- YMT China
- Employees
- MCRB N/A
- YMT N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- YMT EDP Services
- Sector
- MCRB Health Care
- YMT Technology
- Exchange
- MCRB Nasdaq
- YMT Nasdaq
- Market Cap
- MCRB 144.8M
- YMT 172.7M
- IPO Year
- MCRB 2015
- YMT 2025
- Fundamental
- Price
- MCRB $16.87
- YMT $1.22
- Analyst Decision
- MCRB Hold
- YMT
- Analyst Count
- MCRB 3
- YMT 0
- Target Price
- MCRB $14.33
- YMT N/A
- AVG Volume (30 Days)
- MCRB 88.5K
- YMT 33.5K
- Earning Date
- MCRB 11-05-2025
- YMT 01-01-0001
- Dividend Yield
- MCRB N/A
- YMT N/A
- EPS Growth
- MCRB N/A
- YMT N/A
- EPS
- MCRB 0.62
- YMT N/A
- Revenue
- MCRB $351,000.00
- YMT $21,547,440.00
- Revenue This Year
- MCRB N/A
- YMT N/A
- Revenue Next Year
- MCRB N/A
- YMT N/A
- P/E Ratio
- MCRB $26.91
- YMT N/A
- Revenue Growth
- MCRB N/A
- YMT 19.68
- 52 Week Low
- MCRB $6.53
- YMT $1.18
- 52 Week High
- MCRB $24.67
- YMT $6.05
- Technical
- Relative Strength Index (RSI)
- MCRB 51.80
- YMT N/A
- Support Level
- MCRB $12.48
- YMT N/A
- Resistance Level
- MCRB $14.35
- YMT N/A
- Average True Range (ATR)
- MCRB 1.18
- YMT 0.00
- MACD
- MCRB 0.22
- YMT 0.00
- Stochastic Oscillator
- MCRB 80.50
- YMT 0.00
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About YMT Yimutian Inc. American Depositary Shares
Yimutian Inc is the largest agricultural B2B platform in mainland China. It provide a comprehensive set of digital solutions to facilitate agricultural product transactions, ranging from searching, matching, to transaction facilitation and settlement. The company pride itself as the go-to platform for merchants by leveraging its inventive technology and industry know-how. Its platform had over 38 million merchants. It has also established approximately 12 offline stores in mainland China to trade agricultural products at cultivation and production sites with sellers and buyers.